SPARX BIOPHARMACEUTICAL CORP

SparX Biopharmaceutical Corp. is a research-based development-stage biopharmaceutical company, dedicated to the mission of strengthening human immunity using robust antibody therapies through the discovery and development of innovative immuno-oncology agents. Equipped with big data analytical techniques, such as machine learning algorithms, SparX extracts potential interactions from large volumes of complex multi-dimensional public information. Mechanistic pharmacological analyses coupled with in vitro and in vivo evaluations using the syngeneic, transgenic and humanized mouse models, enables SparXs focus on developing novel or best-in-class therapeutics demonstrating substantial advantages over existing therapies. Target discovery and validation has historically been the bottleneck in drug development. SparX...

Antibody discovery,phage display,hybridoma technology,antibody manufacturing,ai-assisted target mining,from target id to ind filing,antibody-drug conjugate development,pharmaceutical development,pharmaceutical production,and crdmo service

Sparx biopharmaceutical corp operates in the Pharmaceutical manufacturing industry.

Sparx biopharmaceutical corp's revenue is 11m - 100m

Sparx biopharmaceutical corp has 11 - 50 employees.